Total Payments
$9,367
2024 Payments
$1,450
Companies
59
Transactions
589
Medicare Patients
6,156
Medicare Billing
$523,942
Payment Breakdown by Category
Food & Beverage$9,303 (99.3%)
Education$63.73 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,303 | 586 | 99.3% |
| Education | $63.73 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,468 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,250 | 62 | $0 (2024) |
| Lilly USA, LLC | $802.79 | 57 | $0 (2024) |
| ABBVIE INC. | $654.08 | 49 | $0 (2024) |
| Amgen Inc. | $567.84 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $558.99 | 35 | $0 (2024) |
| PFIZER INC. | $383.54 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $293.49 | 21 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $247.33 | 22 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $241.47 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,450 | 86 | Novo Nordisk Inc ($355.44) |
| 2023 | $1,641 | 100 | Novo Nordisk Inc ($395.35) |
| 2022 | $1,667 | 102 | ABBVIE INC. ($275.06) |
| 2021 | $1,955 | 127 | AbbVie Inc. ($276.15) |
| 2020 | $630.97 | 43 | AstraZeneca Pharmaceuticals LP ($128.46) |
| 2019 | $658.73 | 50 | Supernus Pharmaceuticals, Inc. ($139.65) |
| 2018 | $842.59 | 47 | AstraZeneca Pharmaceuticals LP ($128.53) |
| 2017 | $521.91 | 34 | AstraZeneca Pharmaceuticals LP ($135.05) |
All Payment Transactions
589 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes Care | ||||||
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Athena Bioscience, LLC | NEXICLON XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.18 | General |
| Category: CARDIOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Bone Health | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Diabetes Care | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: DIABETES | ||||||
| 09/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: PAIN | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.03 | General |
| 09/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,773 | 2,699 | $258,613 | $170,694 |
| 2022 | 24 | 1,469 | 2,202 | $210,921 | $126,206 |
| 2021 | 26 | 1,467 | 2,162 | $197,884 | $125,498 |
| 2020 | 25 | 1,447 | 2,213 | $164,679 | $101,545 |
Total Patients
6,156
Total Services
9,276
Medicare Billing
$523,942
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 314 | 636 | $76,600 | $48,551 | 63.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 296 | 361 | $60,846 | $35,234 | 57.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 93 | 228 | $17,291 | $13,223 | 76.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 244 | $20,659 | $11,966 | 57.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 131 | 132 | $9,693 | $9,334 | 96.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 65 | $11,054 | $8,324 | 75.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 65 | 99 | $7,612 | $5,741 | 75.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 61 | $6,957 | $5,353 | 76.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $4,904 | $4,795 | 97.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 50 | $6,235 | $4,384 | 70.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 133 | 134 | $4,028 | $3,835 | 95.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 17 | 17 | $7,126 | $3,394 | 47.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 91 | 111 | $5,865 | $2,970 | 50.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $4,999 | $2,729 | 54.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 71 | $3,367 | $2,630 | 78.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $1,602 | $1,570 | 98.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 28 | 37 | $2,272 | $1,553 | 68.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 29 | $1,431 | $992.89 | 69.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 17 | 28 | $1,697 | $974.68 | 57.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 16 | 34 | $1,357 | $921.06 | 67.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $855.52 | $816.34 | 95.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 48 | $671.45 | $420.90 | 62.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 18 | $554.73 | $387.29 | 69.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 32 | 37 | $505.12 | $286.70 | 56.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 14 | 39 | $236.19 | $171.03 | 72.4% |
About Dr. Jason Dansby, MD
Dr. Jason Dansby, MD is a Family Medicine healthcare provider based in Muskogee, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437151578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Dansby, MD has received a total of $9,367 in payments from pharmaceutical and medical device companies, with $1,450 received in 2024. These payments were reported across 589 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($9,303).
As a Medicare-enrolled provider, Dansby has provided services to 6,156 Medicare beneficiaries, totaling 9,276 services with total Medicare billing of $523,942. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Muskogee, OK
- Active Since 06/01/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437151578
Products in Payments
- FARXIGA (Drug) $592.38
- Ozempic (Drug) $552.07
- TRELEGY ELLIPTA (Drug) $458.74
- VRAYLAR (Drug) $319.59
- TRULICITY (Drug) $310.14
- BREZTRI (Drug) $289.55
- Wegovy (Drug) $277.54
- EMGALITY (Drug) $276.29
- JARDIANCE (Drug) $272.74
- EVENITY (Biological) $244.37
- UBRELVY (Drug) $242.43
- Rybelsus (Drug) $236.71
- TROKENDI XR (Drug) $222.90
- BELSOMRA (Drug) $216.56
- NURTEC ODT (Drug) $203.62
- TRINTELLIX (Drug) $169.02
- Kerendia (Drug) $164.22
- XIFAXAN (Drug) $155.34
- Otezla (Drug) $143.28
- Saxenda (Drug) $139.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Muskogee
Dr. James Beebe, M.d, M.D
Family Medicine — Payments: $63,540
Family Medicine $63,540
Dr. Brad Mcintosh, Md, MD
Family Medicine — Payments: $12,751
Family Medicine $12,751
Jeremy Ross, M.d, M.D
Family Medicine — Payments: $7,971
Family Medicine $7,971
Dr. Leticea Newton, Md, MD
Family Medicine — Payments: $4,243
Family Medicine $4,243
John Fell, Do, DO
Family Medicine — Payments: $4,091
Family Medicine $4,091
Rebekah Kriegsman, Do, DO
Family Medicine — Payments: $2,936
Family Medicine $2,936